Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Specialty Hospitals | | | | | 2,244.9 | 2,198.1 | 2,197.5 | 2,095.5 |
Outpatient Rehabilitation | | | | 810.0 | 819.4 | 777.2 | 751.3 | 708.9 |
Other | | | | 0.7 | 0.7 | 0.4 | 0.1 | 0.1 |
Other | | | | 3,078.0 | 129.3 | 22.8 | 100.5 | 60.8 |
Total revenues | 5,081.3 | 4,365.2 | 4,217.5 | 3,888.7 | 3,194.3 | 2,998.4 | 3,049.4 | 2,865.3 |
Revenue growth [+] | 16.4% | 3.5% | 8.5% | 21.7% | 6.5% | -1.7% | 6.4% | 19.9% |
Specialty Hospitals | | | | | 2.1% | 0.0% | 4.9% | 23.1% |
Outpatient Rehabilitation | | | | -1.1% | 5.4% | 3.4% | 6.0% | 3.0% |
Other | | | | 0.4% | 106.0% | 184.6% | 1.7% | 12.0% |
Cost of goods sold | 4,341.1 | 3,735.3 | 3,665.4 | 3,211.5 | 2,582.3 | 2,495.5 | 2,443.6 | 2,308.6 |
Gross profit | 740.2 | 629.9 | 552.1 | 677.2 | 612.0 | 502.9 | 605.9 | 556.7 |
Gross margin | 14.6% | 14.4% | 13.1% | 17.4% | 19.2% | 16.8% | 19.9% | 19.4% |
Selling, general and administrative [+] | 121.3 | 114.0 | 106.9 | 92.1 | 85.2 | 76.9 | 66.2 | 62.4 |
General and administrative | 121.3 | 114.0 | 106.9 | 92.1 | 85.2 | 76.9 | 66.2 | 62.4 |
Equity in earnings | 21.9 | 21.1 | 19.9 | 16.8 | 7.0 | 2.5 | 7.7 | 2.9 |
Other operating expenses | | | | 205.4 | 173.9 | 60.2 | 139.5 | 112.1 |
Adjusted EBITDA | 664.2 | 556.2 | 482.5 | 411.6 | 371.1 | 375.3 | 405.8 | 386.0 |
Adjusted EBITDA margin | 13.1% | 12.7% | 11.4% | 10.6% | 11.6% | 12.5% | 13.3% | 13.5% |
Stock-based compensation | 23.3 | 19.3 | 17.4 | 15.0 | 11.2 | 7.0 | 5.7 | 3.7 |
EBITDA [+] | 640.8 | 536.9 | 465.1 | 396.6 | 359.9 | 368.3 | 407.9 | 385.2 |
EBITDA growth | 19.3% | 15.4% | 17.3% | 10.2% | -2.3% | -9.7% | 5.9% | 26.5% |
EBITDA margin | 12.6% | 12.3% | 11.0% | 10.2% | 11.3% | 12.3% | 13.4% | 13.4% |
Depreciation and amortization | 201.7 | 160.0 | 145.3 | 105.0 | 68.4 | 64.4 | 63.3 | 71.5 |
EBIT [+] | 439.2 | 376.9 | 319.8 | 291.6 | 291.5 | 303.9 | 344.6 | 313.6 |
EBIT growth | 16.5% | 17.9% | 9.7% | 0.0% | -4.1% | -11.8% | 9.9% | 33.1% |
EBIT margin | 8.6% | 8.6% | 7.6% | 7.5% | 9.1% | 10.1% | 11.3% | 10.9% |
Interest expense, net [+] | 198.5 | 154.7 | 170.1 | 112.8 | 85.4 | | 95.0 | 98.9 |
Interest expense | 198.5 | 154.7 | 170.1 | 112.8 | 85.4 | | 95.0 | 99.2 |
Interest income | | | | | | | | 0.3 |
Other income (expense), net [+] | -5.1 | -19.8 | 31.0 | 29.6 | -2.3 | -106.1 | -6.1 | -31.0 |
Gain (loss) on debt retirement | -14.2 | -19.7 | -11.6 | | -2.3 | -18.7 | -6.1 | -31.0 |
Other non-operating gains/losses | | | | 29.6 | | | | |
Other | | | | 29.6 | | | | |
Pre-tax income | 235.6 | 202.5 | 180.7 | 208.4 | 203.8 | 197.8 | 243.6 | 183.7 |
Income taxes | 58.6 | -18.2 | 55.5 | 72.4 | 75.6 | 74.8 | 89.7 | 71.0 |
Tax rate | 24.9% | | 30.7% | 34.8% | 37.1% | 37.8% | 36.8% | 38.6% |
Minority interest | 39.1 | 43.5 | 9.9 | 5.3 | 7.5 | 8.6 | 5.7 | 4.9 |
Net income | 137.8 | 177.2 | 115.4 | 130.7 | 120.6 | 114.4 | 148.2 | 107.8 |
Net margin | 2.7% | 4.1% | 2.7% | 3.4% | 3.8% | 3.8% | 4.9% | 3.8% |
|
Basic EPS [+] | $1.06 | $1.37 | $0.90 | $1.03 | $0.93 | $0.84 | $1.07 | $0.72 |
Growth | -22.9% | 52.2% | -12.0% | 9.7% | 11.9% | -21.8% | 49.1% | 46.9% |
Diluted EPS [+] | $1.06 | $1.37 | $0.90 | $1.02 | $0.93 | $0.83 | $1.07 | $0.72 |
Growth | -22.9% | 52.1% | -11.9% | 9.8% | 11.6% | -21.7% | 49.0% | 46.9% |
|
Dividends per share [+] | | | | $0.10 | $0.40 | $0.30 | $1.50 | |
Growth | | | -100.0% | -75.0% | 33.3% | -80.0% | | |
|
Shares outstanding (basic) [+] | 130.2 | 129.0 | 127.8 | 127.5 | 129.0 | 136.9 | 138.8 | 150.5 |
Growth | 0.9% | 0.9% | 0.3% | -1.2% | -5.7% | -1.4% | -7.8% | -5.5% |
Shares outstanding (diluted) [+] | 130.3 | 129.1 | 128.0 | 127.8 | 129.5 | 137.0 | 139.0 | 150.7 |
Growth | 0.9% | 0.9% | 0.2% | -1.3% | -5.5% | -1.4% | -7.8% | -5.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|